8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001628280-17-002533
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading cerc8-k20170313.htm…